Skip to main content
Clinical Trials/NL-OMON56037
NL-OMON56037RecruitingNot Applicable

Improving the algorithm and preliminary assessment of the performance of 3D multiparametric ultrasound for the detection, grading and localization of prostate cancer - 3D multiparametric ultrasound for the detection of prostate cancer

Academisch Medisch Centrum0 sites715 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
715

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational invasive

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Men >=18 years with a clinical suspicion of prostate cancer or confirmed
  • prostate cancer.
  • Scheduled for either systematic and/or targeted biopsy after mpMRI examination
  • or radical prostatectomy

Exclusion Criteria

  • - No mpMRI performed prior to prostate biopsy or radical prostatectomy
  • - A history of chemotherapy for PCa or currently being treated with
  • chemotherapy for PCa.
  • - A patient history that includes any of the following prostate related
  • interventions:
  • o Brachytherapy or external radiotherapy for PCa;
  • o Focal therapy for prostate cancer;
  • o Prostate biopsy within the last 30 days.
  • - Hormonal therapy for prostate cancer within the last six months
  • - A patient history with a cardiac right to left shunt.
  • - Current treatment with dobutamine
  • - Known severe pulmonary hypertension (pulmonary artery pressure >90 mmHg),
  • uncontrolled systemic hypertension or respiratory distress syndrome
  • - Incapable of understanding the language in which the patient information is
  • - Allergic reaction to previous ultrasound contrast administration.

Investigators

Similar Trials